• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » European Commission opens antitrust investigation of Align Technology clear aligners

European Commission opens antitrust investigation of Align Technology clear aligners

July 1, 2026 By Sean Whooley

Align Technology Invisalign Palatal Expander
The Invisalign palatal expander. [Image courtesy of Align Technology]
The European Commission announced the opening of a formal antitrust investigation into Align Technology (Nasdaq:ALGN).

According to a news release, the EC wants to assess a potential breach of European Union competition rules. It said this centers around the alleged tying of Align’s iTero intra-oral scanners to its dental clear aligners branded as Invisalign. The investigation follows a complaint by a competitor.

The EC says this marks its first formal antitrust investigation in the medical device sector as well.

Intra-oral scanners represent the digital entry point into the clear aligner market, according to the EC. It opened this investigation because it has concerns that Align may have “unfairly leveraged” its Invisalign offering by “effectively forcing dental professionals to purchase the iTero scanner if they wish to order Invisalign for their patients.”

The investigation focuses on the company’s interoperability strategy. In it, the EC alleges a refusal to approve competing scanners for the automated submission to Align of digital scans for Invisalign orders since 2017. Additionally, it alleges a refusal to accept dental professionals’ submissions of scans generated by other intra-oral scanners.

“This creates a closed ecosystem around Invisalign,” the EC alleges. “By limiting the possibility to order Invisalign clear aligners using competing intra-oral scanners, Align Technology may be shielding its iTero scanners from competition while protecting its possible dominance in the clear aligner market.”

Align Technology responds to European Commission investigation

In a press release issued by Align Technology, the company said it remains committed to conducting business “with integrity and in full compliance with global competition laws.”

The company said its iTero platform supports an open, diverse digital dental ecosystem. It said the scans can export to order aligners other than Invisalign. Align also said it maintains a scan acceptance policy designed to ensure clinical quality, patient safety and system reliability.

“The Commission’s step is purely procedural and allows it to gather information,” the company wrote. “It does not reflect a conclusion on the merits of the case, nor does it constitute an accusation or a finding of wrongdoing. The opening of an investigation does not prejudge its outcome.

“Align is confident that any review of Align’s scanner and scan acceptance policies will reflect the robust and dynamic nature of the teeth-straightening market and believes its practices comply with applicable competition laws. We will cooperate fully and engage constructively with the Commission through the appropriate channels.”

Filed Under: Business/Financial News, Dental, Digital Health, Health Technology, Legal News, Regulatory/Compliance, Software / IT Tagged With: Align Technology, European Commission

More recent news

  • Massachusetts Life Sciences Center offers grants to lower medtech commercial risk
  • The 10 largest medical device companies
  • CSL to drop Terumo for Haemonetics in US plasma collection supply deal
  • How 5 medtech CEOs design for access
  • Butterfly Network to chase ultrasound brain-computer interfaces with newcomer Bridge Neurotech

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy